Daniela Schmitter

Daniela Schmitter has a diverse work experience in the field of clinical research and operations. Daniela is currently working at Alentis Therapeutics since 2022, where they hold the position of Head of Clinical Operations for Fibrosis and also serves as Clinical Operations Program Leader. Previously, they worked at Polyphor Ltd from 2017 to 2021, where they held various roles including Clinical Scientist and Senior Clinical Development Project Manager. Prior to that, they were employed at Momentum Research, Inc. from 2010 to 2017, working as a Senior Clinical Project Manager and Project Manager. Daniela also gained experience as a Senior Clinical Research Associate at Averion International from 2007 to 2009 and as a Clinical Research Associate from 2007 to 2008. Earlier in their career, they worked as a PhD Student at the Friedrich Miescher Institute for Biomedical Research from 2004 to 2006 and as a Laboratory Expert at Novartis Institutes for BioMedical Research from 2003 to 2004.

Daniela Schmitter holds a Doctor of Philosophy (PhD) degree from the University of Groningen, which they obtained from 2012 to 2016. Daniela'sfield of study during their PhD was RNA silencing, specifically in the field of Cardiology. Prior to their PhD, they attended Fachhochschule Jena from 1999 to 2003, where they earned a Dipl. Ing. in Medical Engineering and Biotechnology.